Literature DB >> 9663831

Absence of gaseous symptoms during ingestion of commercial fibre preparations.

L Zumarraga1, M D Levitt, F Suarez.   

Abstract

BACKGROUND: While fibre is believed to cause gaseous symptoms, a study in healthy volunteers showed no increase in flatulence when the diet was supplemented with fermentable (psyllium) or non-fermentable (methylcellulose) fibre. However, extrapolation of this observation to subjects who use fibre is arguable since these individuals may have a propensity to gaseousness. In the present study, gaseous complaints during fibre ingestion were assessed in subjects who believed that a previous exposure to fibre induced gas.
METHODS: In a double-blind protocol, subjects were randomized to one of four treatment periods, during which the regular diet was supplemented for 1-week periods with two daily doses of: placebo 10 g, psyllium 3.4 g, methylcellulose 2 g or lactulose 5 g. A symptom diary was maintained for 1-week periods on or off treatment.
RESULTS: During treatment, the lactulose group passed gas significantly more often than did the psyllium or the methylcellulose group (P = 0.01). No other symptom was significantly different among the treatment groups.
CONCLUSIONS: (1) psyllium and methylcellulose did not cause greater gaseous symptomatology than did placebo in subjects who believed that these preparations caused gas; and (2) subjects commonly misidentify dietary components that cause gaseous symptoms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9663831     DOI: 10.1046/j.1365-2036.1997.00250.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

1.  Dietary fiber supplementation for fecal incontinence: a randomized clinical trial.

Authors:  Donna Z Bliss; Kay Savik; Hans-Joachim G Jung; Robin Whitebird; Ann Lowry; Xiaoyan Sheng
Journal:  Res Nurs Health       Date:  2014-08-23       Impact factor: 2.228

2.  Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.

Authors:  Heather E Rasmussen; Bruce Hamaker; Kumar B Rajan; Ece Mutlu; Stefan J Green; Michael Brown; Amandeep Kaur; Ali Keshavarzian
Journal:  Nutr Res       Date:  2017-06-02       Impact factor: 3.315

3.  Symptoms associated with dietary fiber supplementation over time in individuals with fecal incontinence.

Authors:  Donna Z Bliss; Kay Savik; Hans-Joachim G Jung; Robin Whitebird; Ann Lowry
Journal:  Nurs Res       Date:  2011 May-Jun       Impact factor: 2.381

4.  Managing Functional Disturbances in Patients with Inflammatory Bowel Disease.

Authors:  Philip M Ginsburg; Theodore M Bayless
Journal:  Curr Treat Options Gastroenterol       Date:  2005-06

5.  Micronutrient status of individuals with overweight and obesity following 3 months' supplementation with PolyGlycopleX (PGX®) or psyllium: a randomized controlled trial.

Authors:  Sebely Pal; Jenny McKay; Suleen Ho; Monica Jane; Roland J Gahler; Simon Wood
Journal:  BMC Nutr       Date:  2022-05-03

Review 6.  [Dietary fibre: more than a matter of dietetics. I. Compounds, properties, physiological effects].

Authors:  Friedrich Trepel
Journal:  Wien Klin Wochenschr       Date:  2004-07-31       Impact factor: 1.704

7.  Evidence-Based Approach to Fiber Supplements and Clinically Meaningful Health Benefits, Part 2: What to Look for and How to Recommend an Effective Fiber Therapy.

Authors:  Johnson W McRorie
Journal:  Nutr Today       Date:  2015-03

8.  An investigation of fecal volatile organic metabolites in irritable bowel syndrome.

Authors:  Iftikhar Ahmed; Rosemary Greenwood; Ben de Lacy Costello; Norman M Ratcliffe; Chris S Probert
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

9.  Aerophagia and Intestinal Gas.

Authors:  Eamonn M. M. Quigley
Journal:  Curr Treat Options Gastroenterol       Date:  2002-08

10.  Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.

Authors:  Natalia Zeber-Lubecka; Maria Kulecka; Filip Ambrozkiewicz; Agnieszka Paziewska; Krzysztof Goryca; Jakub Karczmarski; Tymon Rubel; Wojciech Wojtowicz; Piotr Mlynarz; Lukasz Marczak; Roman Tomecki; Michal Mikula; Jerzy Ostrowski
Journal:  Gut Microbes       Date:  2016-07-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.